Immunoprotective activities of a Streptococcus suis pilus subunit in murine models of infection

Manuela Garibaldi1, Manuel J Rodríguez-Ortega, Francesca Mandanici

  • 1The Elie Metchnikoff Department, University of Messina, Messina I-98125, Italy.

Vaccine
|January 19, 2010
PubMed

Insights

Researchers identified a novel pilus protein, PAPI-2b, in Streptococcus suis. Immunizing mice with this protein fragment significantly protected them against S. suis infection, highlighting its vaccine potential.

Area of Science:

  • Microbiology
  • Bacteriology
  • Vaccinology

Background:

  • Gram-positive bacterial pili are crucial virulence factors and potential vaccine targets.
  • Streptococcus suis is an emerging zoonotic pathogen causing severe human infections.
  • The role and immunoprotective capacity of S. suis pilus components remain unexplored.

Purpose of the Study:

  • To identify and characterize novel pilus components of Streptococcus suis serotype 2.
  • To evaluate the immunoprotective potential of a newly identified pilus protein against S. suis infection.

Main Methods:

  • Selective proteomics was employed to identify surface proteins.
  • Bioinformatics analysis, immunoblotting, and immunoelectron microscopy were used for characterization.
  • Mice were immunized with recombinant protein fragments (PAPI-2b) and challenged with S. suis.

Main Results:

  • A novel surface protein with ancillary pilus subunit characteristics was identified and named PAPI-2b.
  • Bioinformatics, immunoblot, and immunoelectron microscopy confirmed its pilus-associated nature.
  • Immunization with PAPI-2b fragments conferred significant protection against systemic S. suis infection in mice.

Conclusions:

  • PAPI-2b is a surface protein of Streptococcus suis serotype 2 with pilus-associated features.
  • PAPI-2b demonstrates significant immunoprotective potential, making it a promising vaccine candidate against S. suis infections.

Related Concept Videos